Advanced Cancer Therapeutics' Series A - II Round

Advanced Cancer Therapeutics raised a round of funding on November 01, 2007. Investors include Yearling Fund.

Advanced Cancer Therapeutics (ACT) is is focused on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most…

Articles about Advanced Cancer Therapeutics' Series A - II Round: